Immutep (NASDAQ:IMMP) Stock Passes Below 50 Day Moving Average of $2.45

Immutep Limited (NASDAQ:IMMP) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.45 and traded as low as $2.40. Immutep shares last traded at $2.59, with a volume of 1,402,552 shares.

Immutep Stock Performance

The company’s fifty day moving average price is $2.45 and its two-hundred day moving average price is $2.23.

Institutional Trading of Immutep

An institutional investor recently bought a new position in Immutep stock. PFG Investments LLC purchased a new stake in shares of Immutep Limited (NASDAQ:IMMP) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,000 shares of the biotechnology company’s stock, valued at approximately $119,000. PFG Investments LLC owned about 0.06% of Immutep at the end of the most recent reporting period. Institutional investors own 2.32% of the company’s stock.

Immutep Company Profile

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.